Skip to main content
. 2024 Mar 26;46(4):2884–2925. doi: 10.3390/cimb46040181
FDA Food and Drug Administration
UAE Ultrasound-assisted extraction
RSM Response Surface Methodology
HPLC High-performance liquid chromatography
LC-MS Liquid chromatography tandem mass spectrometry
DES Deep eutectic solvent
AFO Algar–Flynn–Oyamada method
BKVK Baker–Venkataraman method
PTZ Pentylenetetrazol
NRG Neuregulin
CDK Cyclin-dependent kinase
IC50 Half maximal inhibitory concentration
COX-2 Cyclooxygenase-2
ITS Internal Transcribed Spacer
CHS Chalcone synthase
FNS Flavonol synthase
CHI Chalcone isomerase
IFS Isoflavone synthase
F3′H Flavonoid 3′-hydroxylase
PAL Phenylalanine ammonia-lyase
TAL Tyrosine ammonia-lyase
C4H Cinnamic acid-4-hydroxylase
4CL 4-coumaroyl-CoA
PEP Precursors 2-(phenoloxy) prop-2-en-1-olate
E4P (S)-2-hydroxy-4-oxobutyl dihydrogen phosphate
TcCGT Trollius chinensis C-glycosyltransferase
GmSUS Glycine max sucrose synthase
DPPH 2-diphcnyl-l-picrylhydrazyl
ABTS 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
ROS Reactive oxygen species
EE Ethanolic extract
FG Flavonoid glycosides
NF-κB Nuclear factor-kappa B
5-HT 5-hydroxytryptamine
PGE2 Prostaglandin E2
HO-1 Heme oxygenase 1
Nrf2 Nuclear factor erythroid 2-related factor 2
LTB4 Leukotrienes B4
TNF-α Tumor necrosis factor-alpha
IL-6 Interleukin-6
IL-8 Interleukin-8
TLR4 Toll-like receptors 4
Akt Protein kinase B
NQO1 NAD(P)H: quinone oxidoreductase 1
MyD88 Myeloid differentiation primary response 88
p38MAPK Phospho-p38 mitogen-activated protein kinases
JNK c-Jun N-terminal kinase; 6-MeOF, 6-methoxyflavone
LDH Lactate dehydrogenase
CK-MB Creatine kinase muscle/brain
CABG Coronary artery bypass grafting
CVD Cardiovascular disease
PEPCK Phosphoenolpyruvate carboxykinase
G-6-Pase Glucose-6-phosphatase
ACC Acetyl coenzyme A carboxylesterase
IRS-2 Insulin receptor substrate-2
GLUT4 Glucose transporter protein 4
IR Insulin-resistant
PI3K Phosphatidylinositol 3-kinase
IRS-1 Insulin receptor substrate-1
GSK-3β Phosphoglycogen synthase kinase
AGEs advanced glycosylation end products
NMR Nuclear magnetic resonance spectroscopy
MIC Minimum inhibitory concentration
TC Total cholesterol
TG Triacylglycerol
TBIL total bilirubin
NAFLD Non-alcoholic fatty liver disease
A2Ar Adenosine A2a receptor
ERK Extracellular regulated protein kinases
MMP-2 Matrix Metallopeptidase 2
TGF-β1 Tubuloglomerular feedback β1
BLM Bleomycin
LC3 Microtubule-associated protein1 light chain 3
PINK1 PTEN-induced putative kinase 1
LAMP1 Lysosome-associated membrane proteins 1
TFEB Transcription factor EB
EMT Epithelial–mesenchymal transition
SAPK Stress-activated protein kinase
STAT-1 Signal transducer and activator of transcription 1
SAPK Stress-activated protein kinase; mTOR, mammalian target of rapamycin
VEGF Vascular endothelial growth factor
Bcl-2 B-cell lymphoma-2
Bax BCL2-associated X
PLK1 Polo-like kinase
PPARγ Peroxisome proliferator-activated receptors γ
TFH Hippophae rhamnoides
PRKCA Protein kinase C alpha
IGF-1 Insulin-like growth factor-1
UCP2 uncoupling protein 2
GLP-1R Glucagon-like peptide-1 receptor
EGCG Epigallocatechin gallate
TBARS Thiobarbituric acid reactive substances
FAS fatty acid synthase; KGM, Konjac glucomannan
GPx Glutathione peroxidase
TSA Thiolated sodium alginate
GPx Glutathione peroxidase
PVA Polyvinyl alcohol
SA Sodium alginate
ALOX5 Arachidonic acid-5-lipoxygenase
MMP Matrix metalloproteinases
LNQ-MF Luteolin, Naringenin and Quercetin-loaded Micellar Formulation
T2DM diabetes mellitus type 2
Sirt3 recombinant Sirtuin 3
YAP1 Yes-associated protein 1
HMC Hesperidin methyl chalcone